SpringWorks Therapeutics Newsroom

J.P. Morgan Sticks to Their Buy Rating for Springworks Therapeutics (SWTX)

TipRanksNov 21 20:08

SpringWorks Therapeutics Initiated at Outperform by Evercore ISI Group

Dow JonesNov 21 01:11

SpringWorks Therapeutics Analyst Ratings

BenzingaNov 21 01:01

Evercore Initiates SpringWorks Therapeutics(SWTX.US) With Buy Rating, Announces Target Price $60

Futu NewsNov 20 21:33

A Quick Look at Today's Ratings for SpringWorks Therapeutics(SWTX.US), With a Forecast Between $58 to $74

Futu NewsNov 13 21:05

Barclays Sticks to Its Buy Rating for Springworks Therapeutics (SWTX)

TipRanksNov 13 18:21

Buy Rating Reaffirmed for Springworks Therapeutics Amid Promising Outlook for Ogsiveo and Mirdametinib

TipRanksNov 13 18:08

SpringWorks Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow JonesNov 13 00:27

Springworks Therapeutics: Strong Cash Position and Promising Drug Approval Outlook Justify Buy Rating

TipRanksNov 12 23:48

TD Cowen Maintains SpringWorks Therapeutics(SWTX.US) With Buy Rating, Maintains Target Price $63

Futu NewsOct 21 19:31

TD Cowen Remains a Buy on Springworks Therapeutics (SWTX)

TipRanksOct 21 18:55

SpringWorks Therapeutics Is Maintained at Overweight by JP Morgan

Dow JonesSep 5 06:12

J.P. Morgan Maintains SpringWorks Therapeutics(SWTX.US) With Buy Rating, Raises Target Price to $68

Futu NewsSep 4 19:33

Goldman Sachs Maintains SpringWorks Therapeutics(SWTX.US) With Buy Rating

Futu NewsSep 3 12:31

SpringWorks Therapeutics Analyst Ratings

BenzingaAug 28 22:20

H.C. Wainwright Maintains SpringWorks Therapeutics(SWTX.US) With Buy Rating, Maintains Target Price $76

Futu NewsAug 28 21:31

Wedbush Raises Price Target on SpringWorks Therapeutics to $77 From $75, Maintains Outperform Rating

MT NewswiresAug 28 21:09

Buy Rating Affirmed for Springworks Therapeutics on Strong Outlook for Mirdametinib

TipRanksAug 28 20:37

Springworks Therapeutics (SWTX) Receives a Buy From Barclays

TipRanksAug 8 20:10

Strong Q2 Performance and Promising Drug Pipeline Bolster Buy Rating for Springworks Therapeutics

TipRanksAug 8 19:54